Company / Assets per Share
Revolution Medicines, Inc. Assets per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$12.67
FY2025
5-year range
$10.95 / $22.80
FY2021-FY2025
Trend
-18.5%
vs FY2024
Sector context
#77 of 210
Health Care
What the data says
At $12.67, Revolution Medicines, Inc.'s assets per share ranks #77 of 210 in the Health Care sector. Assets per Share has fluctuated over the past 7 years, ranging from $10.95 in FY2022 to $172.35 in FY2020.
Based on SEC 10-K filings.
12.67 in FY2025 with a 5-year CAGR of -40.7%.
Declined from $22.80 to $12.67 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- +5.0%
- 5-Year CAGR
- -40.7%
- 10-Year CAGR
- -
Sector benchmark
#77 of 210 in Health CareTop 37% of 210This company $12.67 Sector average $296.79
▼
-95.7% below sector average
Key checks
Key Insights
- In FY2025, assets per share decreased 18.5% year-over-year.
- Ranks #77 out of 210 companies in the Health Care sector.
- Peak assets per share was recorded in FY2020.
- Lowest assets per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $12.67 | -18.5% |
| FY2024 | $15.54 | -31.9% |
| FY2023 | $22.80 | +108.2% |
| FY2022 | $10.95 | -1.2% |
| FY2021 | $11.08 | -93.6% |
| FY2020 | $172.35 | +116.7% |
| FY2019 | $79.54 | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026